Plasminogen activator inhibitor-1 modulates adipocyte differentiation. (Q42483651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Plasminogen activator inhibitor-1 modulates adipocyte differentiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alyssa H. Hasty

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Talerngsak Kanjanabuch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Xiubin Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Su-Li Mao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Chuan-Ming Hao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Yi-Wei Tang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

David H Wasserman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Agnes B Fogo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Li-Jun Ma

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

6 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

E103-E113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16144810%20AND%20SRC:MED&resulttype=core&format=json

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Regulation of fasted blood glucose by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Renal fibrosis: not just PAI-1 in the sky.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

PPAR(gamma) and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

21 January 2018

You are what you secrete

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Assessment of endothelial function of the renal vasculature in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Tumour necrosis factor alpha: a key regulator of adipose tissue mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Transcriptional repression of type I procollagen genes during adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00605.2004